What is AstaTech?
Headquartered in Bristol, Pennsylvania, AstaTech has maintained a consistent market presence since its inception in 1996. As a specialized Contract Research Organization (CRO), the company bridges the gap between complex chemical synthesis and large-scale bulk manufacturing. By integrating high-level analytical services with a vast catalog of proprietary chemical products, AstaTech provides essential support for drug discovery and development pipelines. Their business model is predicated on delivering cost-effective, flexible solutions that allow pharmaceutical entities to accelerate their research cycles while maintaining rigorous quality standards. The company's longevity and technical expertise position it as a critical node in the pharmaceutical supply chain, serving a diverse clientele ranging from emerging biotech startups to established global pharmaceutical conglomerates.
How much funding has AstaTech raised?
AstaTech has raised a total of $759K across 2 funding rounds:
Debt
$350K
Debt
$409K
Debt (2020): $350K with participation from PPP
Debt (2021): $409K led by PPP
Key Investors in AstaTech
PPP
Public-Private Partnership
What's next for AstaTech?
The infusion of capital from the latest financing round is expected to catalyze AstaTech's strategic expansion into advanced manufacturing technologies and enhanced analytical capabilities. By leveraging this major strategic investment, the company is well-positioned to optimize its production efficiencies and broaden its service offerings in the drug discovery space. Future growth will likely focus on deepening its footprint in the pharmaceutical services market, potentially through the adoption of automated synthesis platforms and the expansion of its chemical catalog. As the industry shifts toward more complex therapeutic modalities, AstaTech's ability to provide reliable, scalable, and cost-efficient research support will be paramount in maintaining its competitive advantage and driving long-term value for its stakeholders.
See full AstaTech company page
